Literature DB >> 10053196

Phase inversion dynamics of PLGA solutions related to drug delivery.

P D Graham1, K J Brodbeck, A J McHugh.   

Abstract

Dark ground optical microscopy, electron microscopy, and high performance liquid chromatography (HPLC) have been used to quantify the effects of formulation changes on the phase inversion dynamics and in vitro drug release properties of a PLGA-based drug delivery system. Gel growth rates and water influx rates are determined from plots of the square of the respective front motion with time. Results show that additives that accelerate the solution gelation rate at constant morphology result in high initial release rates. Conversely, additives that slow the rate of gelation dramatically reduce the initial drug release rate and lead to a more dense sponge-like morphology. Moreover, the phase inversion dynamics and morphology are the same regardless of whether the solutions are quenched with water, a PBS buffer solution or horse serum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10053196     DOI: 10.1016/s0168-3659(98)00158-8

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  35 in total

1.  Sustained release of human growth hormone from PLGA solution depots.

Authors:  K J Brodbeck; S Pushpala; A J McHugh
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

2.  A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo.

Authors:  Xia Lin; Shenshen Yang; Jingxin Gou; Mingming Zhao; Yu Zhang; Na Qi; Haibing He; Cuifang Cai; Xing Tang; Penghong Guo
Journal:  J Mater Sci Mater Med       Date:  2011-12-15       Impact factor: 3.896

3.  Effect of injection site on in situ implant formation and drug release in vivo.

Authors:  Ravi B Patel; Luis Solorio; Hanping Wu; Tianyi Krupka; Agata A Exner
Journal:  J Control Release       Date:  2010-08-20       Impact factor: 9.776

4.  In vitro and in vivo drug release from a novel in situ forming drug delivery system.

Authors:  Heiko Kranz; Erol Yilmaz; Gayle A Brazeau; Roland Bodmeier
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

5.  In vitro-controlled release delivery system for hydrogen sulfide donor.

Authors:  Hatim Ali; Catherine Opere; Somnath Singh
Journal:  AAPS PharmSciTech       Date:  2014-04-24       Impact factor: 3.246

6.  The Effect of Additives on the Behavior of Phase Sensitive In Situ Forming Implants.

Authors:  Luis Solorio; Divya Sundarapandiyan; Alex Olear; Agata A Exner
Journal:  J Pharm Sci       Date:  2015-07-14       Impact factor: 3.534

Review 7.  Advances in image-guided intratumoral drug delivery techniques.

Authors:  Luis Solorio; Ravi B Patel; Hanping Wu; Tianyi Krupka; Agata A Exner
Journal:  Ther Deliv       Date:  2010-08

Review 8.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

9.  Macroporous acrylamide phantoms improve prediction of in vivo performance of in situ forming implants.

Authors:  Christopher Hernandez; Natalia Gawlik; Monika Goss; Haoyan Zhou; Selva Jeganathan; Danielle Gilbert; Agata A Exner
Journal:  J Control Release       Date:  2016-10-11       Impact factor: 9.776

10.  In situ forming implants exposed to ultrasound enhance therapeutic efficacy in subcutaneous murine tumors.

Authors:  Selva Jeganathan; Emily Budziszewski; Peter Bielecki; Michael C Kolios; Agata A Exner
Journal:  J Control Release       Date:  2020-05-07       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.